Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GW-876167, a 5-HT2C agonist, is used potentially for the treatment of obesity and glaucoma.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | GW-876167, a 5-HT2C agonist, is used potentially for the treatment of obesity and glaucoma. |
別名 | PRX-00933, PNU-183933, GW876167, BVT933, BVT-933 |
分子量 | 315.37 |
分子式 | C16H21N5O2 |
CAS No. | 313658-33-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GW-876167 313658-33-2 GW 876167 PRX-00933 PNU-183933 GW876167 BVT933 PNU 183933 PNU183933 BVT 933 PRX00933 PRX 00933 BVT-933 Inhibitor inhibitor inhibit